From supporting identification of certain cell characteristics to complementing clinical expertise with remote pathologist review, Vetscan Imagyst® AI Masses is designed to assist with challenging cases – giving teams added confidence at the point of care. In this video, Zoetis leaders highlight what these advances mean for the clinic, the pet owner, and the patient.
For veterinary professionals facing diagnostic uncertainty, the ability to distinguish between benign and potentially cancerous cells in real-time can make all the difference – for the care team, the pet owner, and ultimately for the patient.
That’s precisely what is brought to life with Vetscan Imagyst® AI Masses, an advanced artificial intelligence (AI) tool designed to support in-clinic analysis of lymph node and skin/subcutaneous masses.
By applying advanced deep learning algorithms, this new diagnostic capability enables the identification and classification of common skin and subcutaneous masses, and lymph node lesions. These insights are generated at the point of care, allowing veterinary teams to access relevant findings within minutes, helping to reduce wait times for anxious owners and delivering insights while the patient is still in the clinic.
Importantly, this AI-driven analysis doesn’t stand alone. Each sample is scanned for cellular patterns that may indicate malignancy, and when needed, clinics can access remote expert review* from board-certified clinical pathologists. This hybrid approach ensures that practitioners receive real-time screening support while maintaining oversight and diagnostic accuracy.
Together, the technology supports more informed case management, facilitates faster treatment discussions with pet owners, and improves access to quality care, helping to enhance outcomes for veterinary patients. Technology doesn’t replace the veterinarian, the technician or the pathologist – it complements them.
In this video, Richard Goldstein, DVM, DACVIM (SAIM), DECVIM-CA, Global Chief Medical Officer and Head of Medical Affairs at Zoetis and Abhay Nayak, President of Global Diagnostics at Zoetis, share what sets this solution apart – not just its technical ability, but the practical impact on everyday care.
Watch the full video above to explore how Vetscan Imagyst AI Masses is reshaping veterinary diagnostics, and why the fast expert backup is changing how decisions are made, right from the exam room.
AI Masses is the latest capability to be added to Zoetis’s Vetscan Imagyst platform, making it the only commercially available veterinary diagnostics tool of its kind to offer seven unique testing applications in one compact tabletop design: AI Masses, Digital Cytology, AI Urine Sediment, AI Fecal, AI Equine Fecal, AI Dermatology, and AI Blood Smear.
For more information, go to zoetisdiagnostics.com/us/point-of-care/vetscan-imagyst/imagyst-ai-masses
* Additional costs may apply.
All trademarks are the property of Zoetis Services LLC or a related company or a licensor unless otherwise noted. ©2025 Zoetis Services LLC. All rights reserved.
VTS-01776
From exam room tips to practice management insights, get trusted veterinary news delivered straight to your inbox—subscribe to dvm360.